Patient Assistance Programs

GSK offers several patient assistance programs to help eligible individuals without prescription medicine coverage obtain free GSK medicines through the mail. There is no cost associated with getting help from any of our patient assistance programs—GSK does not charge an administrative fee or enrollment fees.

NOTE: Some medicines are only available at a retail pharmacy and are not distributed through mail order. GSK Dollars-off Coupons cannot be used by patients with insurance coverage through a Health Insurance Marketplace Plan/Exchange at this time; however, GSK intends to allow exchange patients to utilize coupons. We are currently updating our coupon systems and expect to make coupons available for exchange patients later this year.

You can enroll in one of our patient assistance programs in 3 easy steps. If at any time you need help enrolling, experienced GSK representatives are available by phone to walk you through the process.

Learn more about the variety of programs that exist.

Is Your Prescription Medicine Included?

An alphabetical list of the GSK medicines included by our patient assistance programs is provided below. To find out whether the medicine you’re taking is included in any GSK patient assistance program, click on the first letter of your medicine’s name. If your medicine is listed, you may further filter by patient assistance program. Then click Update. If your medicine is not in the list it may be because the medicine is not a GSK medicine, or because the medicine is not included in our programs or, based on your income you do not qualify for the patient assistance program.

  • ADVAIR DISKUS® 100/50 (fluticasone propionate 100 mcg and salmeterol 50 mcg inhalation powder) http://us.gsk.com/products/assets/us_advair.pdf
  • ADVAIR DISKUS® 250/50 (fluticasone propionate 250 mcg and salmeterol 50 mcg inhalation powder) http://us.gsk.com/products/assets/us_advair.pdf
  • ADVAIR DISKUS® 500/50 (fluticasone propionate 500 mcg and salmeterol 50 mcg inhalation powder) http://us.gsk.com/products/assets/us_advair.pdf
  • ADVAIR® HFA 115/21 (fluticasone propionate 115 mcg and salmeterol 21 mcg)Inhalation Aerosol http://us.gsk.com/products/assets/us_advair_hfa.pdf
  • ADVAIR® HFA 230/21 (fluticasone propionate 230 mcg and salmeterol 21 mcg)Inhalation Aerosol http://us.gsk.com/products/assets/us_advair_hfa.pdf
  • ADVAIR® HFA 45/21 (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol http://us.gsk.com/products/assets/us_advair_hfa.pdf
  • ALTABAX® (retapamulin ointment), 1% http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022055s002lbl.pdf
  • ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) https://www.gsksource.com/gskprm/htdocs/documents/ANORO-ELLIPTA-PI-MG.PDF
  • ARRANON® (nelarabine) Injection http://us.gsk.com/products/assets/us_arranon.pdf
  • ARZERRA (ofatumumab) Injection http://us.gsk.com/products/assets/us_arzerra.pdf
  • AVANDIA® (rosiglitazone maleate) Tablets http://us.gsk.com/products/assets/us_avandia.pdf
  • AVODART® (dutasteride) Soft Gelatin Tablets http://us.gsk.com/products/assets/us_avodart.pdf
  • BACTROBAN CREAM® (mupirocin calcium cream, 2%) http://us.gsk.com/products/assets/us_bactroban_cream.pdf
  • BACTROBAN® NASAL OINTMENT (mupirocin calcium ointment, 2%) http://us.gsk.com/products/assets/us_bactroban_nasal.pdf
  • BACTROBAN® OINTMENT (mupirocin ointment, 2%) http://us.gsk.com/products/assets/us_bactroban_ointment.pdf
  • BECONASE AQ® (beclomethasone dipropionate, monohydrate ) Nasal Spray, 0.042% http://us.gsk.com/products/assets/us_beconase_aq.pdf
  • BENLYSTA® (belimumab) Injection http://us.gsk.com/products/assets/us_benlysta.pdf
  • BREO ELLIPTA (fluticasone furoate and vilanterol inhalation powder) http://us.gsk.com/products/assets/us_breo_ellipta.pdf
  • Boostrix® – tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine http://us.gsk.com/products/assets/us_boostrix.pdf
  • COREG CR® (carvedilol phosphate extended release capsules) http://us.gsk.com/products/assets/us_coregcr.pdf
  • Cervarix – human papillomavirus vaccine (types 16, 18) - recombinant, adjuvanted http://us.gsk.com/products/assets/us_cervarix.pdf
  • DUAC® Topical Gel (clindamycin phosphate 1%, benzoyl peroxide 5%) http://www.stiefel.com/content/dam/stiefel/globals/documents/pdf/US_Duac_Topical_Gel.pdf
  • EPIVIR-HBV® (lamivudine) Oral Solution http://us.gsk.com/products/assets/us_epivir_hbv.pdf
  • EPIVIR-HBV® (lamivudine) Tablets http://us.gsk.com/products/assets/us_epivir_hbv.pdf
  • Engerix-B® – hepatitis B vaccine (recombinant) http://us.gsk.com/products/assets/us_engerixb.pdf
  • FABIOR™ (tazarotene) Foam http://www.stiefel.com/content/dam/stiefel/globals/documents/pdf/US_Fabior.pdf
  • FLOVENT® DISKUS® 100 mcg (fluticasone propionate inhalation powder, 100 mcg) http://us.gsk.com/products/assets/us_flovent.pdf
  • FLOVENT® DISKUS® 250 mcg (fluticasone propionate inhalation powder, 250 mcg) http://us.gsk.com/products/assets/us_flovent.pdf
  • FLOVENT® DISKUS® 50 mcg (fluticasone propionate inhalation powder, 50 mcg) http://us.gsk.com/products/assets/us_flovent.pdf
  • FLOVENT® HFA 110 mcg (with a dosage counter) (fluticasone propionate inhalation aerosol) http://us.gsk.com/products/assets/us_flovent_hfa.pdf
  • FLOVENT® HFA 220 mcg (with a dosage counter) (fluticasone propionate inhalation aerosol) http://us.gsk.com/products/assets/us_flovent_hfa.pdf
  • FLOVENT® HFA 44 mcg (with a dosage counter) (fluticasone propionate inhalation aerosol) http://us.gsk.com/products/assets/us_flovent_hfa.pdf
  • HYCAMTIN® (topotecan hydrochloride) for Injection http://us.gsk.com/products/assets/us_hycamtin.pdf
  • HYCAMTIN® (topotecan) Capsules http://us.gsk.com/products/assets/us_hycamtin_capsules.pdf
  • Havrix® – hepatitis A vaccine, inactivated https://www.gsksource.com/gskprm/htdocs/documents/HAVRIX.PDF
  • IMITREX® (sumatriptan) Nasal Spray http://us.gsk.com/products/assets/us_imitrex_nasal_spray.pdf
  • JALYN (dutasteride and tamsulosin hydrochloride) Capsules http://us.gsk.com/products/assets/us_jalyn.pdf
  • LAMICTAL® (lamotrigine) Starter Kits http://us.gsk.com/products/assets/us_lamictal.pdf
  • LAMICTAL® (lamotrigine) Tablets, Chewable Dispersible Tablets or Orally Disintegrating Tablets http://us.gsk.com/products/assets/us_lamictal.pdf
  • LAMICTAL® ODT™ (lamotrigine) Patient Titration Kits http://us.gsk.com/products/assets/us_lamictal.pdf
  • LAMICTAL® XR™ http://us.gsk.com/products/assets/us_lamictalxr.pdf
  • LAMICTAL® XR™ (lamotrigine) Patient Titration Kits http://us.gsk.com/products/assets/us_lamictalxr.pdf
  • LOVAZA® (omega-3-acid ethyl esters) Capsules http://us.gsk.com/products/assets/us_lovaza.pdf
  • MALARONE® (atovaquone and proguanil hydrochloride) Tablets http://us.gsk.com/products/assets/us_malarone.pdf
  • MEKINIST® (trametinib) Tablets http://us.gsk.com/products/assets/us_mekinist.pdf
  • MEPRON® (atovaquone) Suspension http://us.gsk.com/products/assets/us_mepron.pdf
  • POTIGA® (ezogabine) Tablets http://us.gsk.com/products/assets/us_potiga.pdf
  • PROMACTA® (eltrombopag) Tablets http://us.gsk.com/products/assets/us_promacta.pdf
  • RELENZA® (zanamivir) inhalation powder for oral inhalation http://us.gsk.com/products/assets/us_relenza.pdf
  • REQUIP® XL™ (ropinirole extended-release tablets) http://us.gsk.com/products/assets/us_requipxl.pdf
  • RYTHMOL® SR (propafenone hydrochloride) extended release Capsules http://us.gsk.com/products/assets/us_rythmolsr.pdf
  • SEREVENT® DISKUS® (salmeterol xinafoate inhalation powder) http://us.gsk.com/products/assets/us_serevent_diskus.pdf
  • SORIATANE® (acitretin) Capsules http://www.stiefel.com/content/dam/stiefel/globals/documents/pdf/US_Soriatane_Capsules.pdf
  • SORILUX® (calcipotriene) Foam http://www.stiefel.com/content/dam/stiefel/globals/documents/pdf/US_Sorilux_Foam.pdf#page=6
  • TAFINLAR® (dabrafenib) Capsules http://us.gsk.com/products/assets/us_tafinlar.pdf
  • TANZEUM™ (albiglutide) for injection, for subcutaneous use https://www.gsksource.com//gskprm/htdocs/documents/TANZEUM-PI-MG-IFU-COMBINED.PDF
  • TYKERB® (lapatinib tablets) http://us.gsk.com/products/assets/us_tykerb.pdf
  • Twinrix® – combined hepatitis A (inactivated virus) and hepatitis B vaccine http://us.gsk.com/products/assets/us_twinrix.pdf
  • VELTIN® Gel (clindamycin phosphate/tretinoin) 1.2%/0.025% http://www.stiefel.com/content/dam/stiefel/globals/documents/pdf/us_veltin.pdf
  • VENTOLIN® HFA (albuterol sulfate HFA inhalation aerosol) http://us.gsk.com/products/assets/us_ventolin_hfa.pdf
  • VERAMYST® (fluticasone furoate) Nasal Spray http://us.gsk.com/products/assets/us_veramyst.pdf
  • VOTRIENT (pazopanib) tablets http://us.gsk.com/products/assets/us_votrient.pdf
  • Update

    GSK Access

    GSK Access provides certain GSK prescription medicines — at no charge — to qualified patients who are enrolled in a Medicare Part D Prescription Drug Plan. You may enroll directly in GSK Access, or with the help of a family member or friend.

    Learn More

    BRIDGES TO ACCESS®

    Bridges to Access provides GSK non-cancer (non-oncology) medicines — at little or no cost — to qualified patients. You may enroll in the program on your own by mail or through an Advocate if medicine is needed that same day.

    Learn More

    COMMITMENT TO ACCESS® Patient Assistance Program

    Commitment to Access provides GSK cancer (oncology) and specialty pharmacy products — at little or no cost — to qualified patients. You must enroll in the program though an Advocate (ie, someone such as a healthcare worker, social worker, or case worker who is involved in the delivery of your healthcare).

    Learn More

    COMMITMENT TO ACCESS® Reimbursement Support Program

    The CTA Reimbursement Support Program helps you find reimbursement for and access to GSK oncology and specialty medicines. In addition to providing reimbursement support, the Reimbursement Support Program can help arrange delivery of your medicine, and can guide you to other resources. The Reimbursement Support Program also includes the GSK Co-Pay Assistance Program for selected oncology and specialty oral medications.

    Learn More

    Immunology Assistance Programs

    Co-pay assistance program and patient assistance program supported jointly by GSK and Human Genome Sciences (HGS). For more information, please call 1-877-423-6597.

    Learn More

    GSK Vaccines Access Program

    GSK Vaccines Access Program provides certain GSK vaccines to adult applicants who meet eligibility requirements.

    Learn More

    Reimbursement Resources Center

    This toll-free reimbursement support program helps patients and healthcare professionals in the U.S. with coverage, coding, and reimbursement issues for certain GSK products.

    Learn More

    You are about to leave a GlaxoSmithKline website. By clicking this link, you will be taken to a website that is independent from GlaxoSmithKline. The site you are linking to is not controlled or endorsed by GlaxoSmithKline and GlaxoSmithKline is not responsible for the content provided on that site.